Status:
COMPLETED
Comparing Opioid Prescription Patterns in Total Joint Arthroplasty Patients
Lead Sponsor:
Rush University Medical Center
Conditions:
Postoperative Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The United States constitutes \<5% of the world's population but over 80% of the opioid supply and 99% of the hydrocodone supply. In 2014, there were 18,893 deaths from prescription drug overdose, and...
Detailed Description
A recent paper by Kim et al prospectively investigated opioid utilization after upper extremity surgery. This study (n=1,416) showed an opioid utilization rate of just 34%, taking an average 8.1 pills...
Eligibility Criteria
Inclusion
- any patient \> 18 years of age scheduled for primary total hip or knee arthroplasty who is not consuming opioids during the 4 weeks prior to surgery
Exclusion
- patients consuming opioids during the 4 weeks prior to surgery
- patients who are allergic to oxycodone or refuse to take oxycodone
- patients with a history of opioid dependence or illegal or "off-label" opioid use
- patients undergoing a revision total knee or total hip arthroplasty
- any patient less than 18 years of age
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 26 2018
Estimated Enrollment :
304 Patients enrolled
Trial Details
Trial ID
NCT03236155
Start Date
July 1 2017
End Date
August 26 2018
Last Update
July 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612